Marinus Pharmaceuticals (NASDAQ:MRNS – Get Free Report) is set to release its earnings data before the market opens on Tuesday, November 7th. Analysts expect Marinus Pharmaceuticals to post earnings of ($0.67) per share for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this link. Marinus Pharmaceuticals […]
Shares of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the nine research firms that are presently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. […]
Marinus Pharmaceuticals, Inc (NASDAQ:MRNS) Receives $21 50 Average Price Target from Analysts theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Cantor Fitzgerald reissued their overweight rating on shares of Marinus Pharmaceuticals (NASDAQ:MRNS – Free Report) in a research report sent to investors on Thursday morning, Benzinga reports. They currently have a $28.00 price target on the biopharmaceutical company’s stock. Other equities analysts have also issued research reports about the stock. Royal Bank of Canada increased […]
Marinus Pharmaceuticals (NASDAQ:MRNS – Free Report) had its target price lifted by LADENBURG THALM/SH SH from $13.00 to $15.50 in a report issued on Wednesday morning, FlyOnTheWall reports. A number of other equities research analysts have also commented on MRNS. Oppenheimer lowered shares of Marinus Pharmaceuticals from an outperform rating to a market perform rating […]